22nd Century Group Announces 1-for-20 Reverse Stock Split and Highly Dilutive Warrant Inducement
XXII is trading near its 52-week low of $0.453 (14% above the low) on light trading volume (0.2× avg).
Summary
22nd Century Group announced a 1-for-20 reverse stock split to maintain its NASDAQ listing and completed a highly dilutive warrant inducement offering, generating $462,800 in cash but using most of it to redeem preferred stock, while creating significant future dilution.
Key Events · Financing and Capital Events · XXII
-
1-for-20 Reverse Stock Split Announced
A 1-for-20 reverse stock split will become effective on June 12, 2026, to regain compliance with NASDAQ Capital Market listing standards. Pre-split outstanding shares of 10.33 million will reduce to approximately 0.52 million post-split.
-
Warrant Inducement Offering Completed
The company received $462,800 in gross cash proceeds from an inducement offering where holders exercised 5.35 million existing warrants at a reduced price of $0.4626 per share (down from $3.57).
-
Significant Preferred Stock Redemption
A substantial portion of the proceeds, $2.01 million, was used to redeem Series B Convertible Preferred Stock, resulting in a net negative cash inflow for the company from this transaction.
-
Future Dilution from New Warrants
New inducement warrants, equal to 100% of the shares exercised from the existing warrants, will be issued with an exercise price of $0.4626, creating significant potential future dilution.
Analysis · XXII · Manufacturing
This 8-K details two critical events for 22nd Century Group, a company already facing substantial doubt about its ability to continue as a going concern. The 1-for-20 reverse stock split, effective June 12, 2026, is a direct measure to regain NASDAQ listing compliance, a common but often negative signal for struggling companies. Concurrently, the company completed a warrant inducement offering, generating $462,800 in gross cash proceeds by inducing holders to exercise existing warrants at a deeply discounted price. However, a significant portion ($2.01 million) of these proceeds was immediately used to redeem Series B Convertible Preferred Stock, resulting in a net negative cash inflow for the company from this transaction. The issuance of new warrants, equal to 100% of the exercised shares, at a low exercise price, creates substantial future dilution risk. These actions highlight the company's urgent need for capital and its precarious financial position.
At the time of this filing, XXII was trading at $0.52 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $2.3M. The 52-week trading range was $0.45 to $257.03. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.